Navigation Links
Concept 400-M

ProductsConcept 400-M
Company Biotrace, Inc.
Item Concept 400-M
Features 
  • Controlled and repeatable rapid transfer interlock - 25 seconds in economy mode or 45 seconds in standard mode to transfer up to 40 plates
  • 15 cm single plate entry system (optional)
  • Humidity control
  • Fluorescent lamp
  • Foot operated halogen lamp
  • Removable front (optional)
  • Gloveless Design
  • Port entry - maintenance free
Description The Concept 400-M incorporates all the familiar and proven features of the Concept 400, but is tailored to interface with the Ruskinn patented gas mixing system.The gas mixing module provides accurate control over oxygen (0.1% - 20% in 0.1% increments), carbon dioxide (0% - 12% in 1% increments) and hydrogen (0% - 10% in 1% increments) components of the mix with integral oxygen sensor and calibration port. The Concept 400-M also has an optional single plate entry system.
Info Biotrace, Inc.
Customer Service: 425.398.7993
Web site: http://www.biotrace.co.uk/

Related medicine products :

1. Concepta Refraction Unit
2. Concept 400
3. Concept 1000
4. Concept Plus
5. Pipetman Concept C10 Single Channel
6. Pipetman Concept® C300 Single Channel
7. Pipetman Concept C100 Single Channel
8. Chromosome Analysis, Products of Conception
9. Electa Essential Concept
TAG: Concept
Breaking Medicine Technology:TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Roper Industries Completes the Acquisition of Verathon, Inc. 2Roper Industries Completes the Acquisition of Verathon, Inc. 3Illness often undiscovered and undertreated among the uninsured 3A Harvard study 59784 1Illness often undiscovered and undertreated among the uninsured 3A Harvard study 59784 2FDA approves GlaxoSmithKlines VOTRIENT 28TM 29 for advanced renal cell cancer 5578 1FDA approves GlaxoSmithKlines VOTRIENT 28TM 29 for advanced renal cell cancer 5578 2FDA approves GlaxoSmithKlines VOTRIENT 28TM 29 for advanced renal cell cancer 5578 3FDA approves GlaxoSmithKlines VOTRIENT 28TM 29 for advanced renal cell cancer 5578 4Checkered history of mother and daughter cells explains cell cycle differences 10424 1Checkered history of mother and daughter cells explains cell cycle differences 10424 2Checkered history of mother and daughter cells explains cell cycle differences 10424 3